The board of Speed Medical Company approved hiring Osoul Arabia for Investment and Financial Consultancy as an independent financial advisor to conduct a fair value study on the sale of Speed Hospital Company.

Speed Medical Company incurred 30.94% year-on-year (YoY) lower consolidated net losses after tax and non-controlling interest at EGP 32.428 million in the first half (H1) of 2025

Speed Medical Company (SPMD) reported a 4.17% year-on-year (YoY) drop in its consolidated net losses after tax and non-controlling interest in the first half (H1) of 2024, incurring EGP 46.962 million, compared to EGP 49.008 million.

Speed Medical Company (SPMD) reported a 5.2% year-on-year (YoY) increase in its consolidated net losses attributable to the parent company in the first quarter (Q1) of 2024 to EGP 25.452 million, compared to EGP 24.183 million.

Speed Medical Company (SPMD) reported a 42.49% year-on-year (YoY) drop in its consolidated net losses attributable to the parent company in 2023, incurring EGP 84.054 million, compared to EGP 146.175 million.

Speed Medical Company (SPMD) reported a 12.46% year-on-year (YoY) drop in its consolidated net losses after tax and non-controlling interest in the first nine months of 2023, incurring EGP 73.018 million, compared to EGP 83.411 million during the same period a year earlier, the company stated on December 24th.

Speed Medical Company (SPMD) reported a 33.8% year-on-year (YoY) drop in its consolidated net losses after tax and non-controlling interest in the first half (H1) of 2023, garnering EGP 49.008 million, compared to EGP 74.036 million.

Speed Medical Company (SPMD) reported a 36.99% year-on-year (YoY) drop in its consolidated net loss after tax in the first quarter (Q1) of 2023.

Speed Medical Company (SPMD) recorded consolidated net losses after tax and non-controlling interests of EGP 146.175 million in 2022, compared to EGP 136.101 million in net profits in 2021.

Established in December 2015 and listed on the EGX in March 2019, Speed Medical is a Cairo-based company that operates in the healthcare sector.

The Financial Regulatory Authority (FRA) has approved publishing the disclosure form submitted by Speed Medical Company (SPMD) to raise its issued and paid-up capital from EGP 221.828 million to EGP 332.743 million via a rights issue to existing shareholders.

The extraordinary general meeting (EGM) of Speed Medical Company (SPMD) has approved increasing its issued and paid-up capital from EGP 221.83 million to EGP 332.74 million.